Deal set to create world’s third-biggest premium spirits company
Like this page on Facebook for updates
Thursday 14 October 2010
Friday 01 October 2010
David Cameron will today announce the membership of a new business advisory group that is set to meet quarterly to provide what Downing Street will describe as "high-level advice on critical business and economic issues facing the country". Its membership is made up of 17 leading businessmen, and two women.
Friday 24 September 2010
Glaxosmithkline was dealt a blow last night when European regulators recommended that its blockbuster diabetes drug, Avandia, should be withdrawn from sale amid fears that the treatment could pose serious health risks.
Thursday 09 September 2010
Glaxosmithkline has appointed Goldman Sachs' leading European mergers and acquisition (M&A) banker, Simon Dingemans, as its finance director.
Wednesday 04 August 2010
Genzyme, the pioneering US biotechnology company whose drugs are among the most expensive in the world, is plotting tactics to extract as much money as possible for its shareholders in a takeover by the French pharmaceutical giant Sanofi-Aventis.
Friday 30 July 2010
AstraZeneca pleased the market with a triple dose of good news yesterday as it won endorsement in the United States for its new blood-thinning drug Brilinta, reported strong results and doubled its share buyback programme.
Saturday 24 July 2010
The makers of two of Britain's best-selling soft drinks, Lucozade and Irn-Bru, have been forced to warn parents that the drinks may cause hyperactivity. A newly introduced EU law compels both drinks to display a warning that they contain artificial colours linked to behavioural problems in young children.
Thursday 22 July 2010
Thursday 22 July 2010
Outlook Farewell, then, SSL International, the condom-to-footwear combine now being lined up for a sale. Nevertheless, investors should not assume – as many in the market seemed to yesterday – that Reckitt Benckiser's offer for the business is absolutely the last word on the sale process. While SSL recommends the Reckitt offer, other bidders may yet emerge.
Friday 16 July 2010
The drugs giant GlaxoSmithKline disclosed yesterday that it has set aside a record £1.57bn to meet legal charges during the second quarter. The money will be ringfenced to end a number of legal wrangles, including most of the claims involving its diabetes treatment Avandia.
Thursday 15 July 2010
Glaxosmithkline's diabetes drug Avandia is safe enough to stay on the market, a panel of 33 medical experts decided last night at the conclusion of a contentious two-day hearing.
Friday 02 July 2010
Dealing with the swine flu outbreak that did not become the pandemic people had feared cost £1.2bn.
Tuesday 29 June 2010
Saturday 12 June 2010
US Outlook: It was a legal battering in the US over the depression medicine Paxil that bounced GlaxoSmithKline into setting up an online register of all its clinical trial data, regardless of whether it had pushed to have the results of a study published in a medical journal. The company had been accused of burying studies which showed the medicine was less effective or more dangerous.
Thursday 10 June 2010
Up to 2,000 women with advanced breast cancer will not be given access on the NHS to a drug that could extend their lives, it was announced yesterday.
Is Britain really full up? Are migrants taking our jobs? Leading academic answers the most common anti-immigration claims
Calais Migrant Crisis: Deputy Mayor of Calais labels Cameron's use of 'swarm' as 'racist' and 'ignorant'
Chris Leslie: Jeremy Corbyn's anti-austerity agenda will harm the poor, says Labour shadow Chancellor
Landlords renting properties to illegal immigrants to face up to five years in prison
While we fixate on Calais, the Home Office is quietly deporting dozens of migrants on 'ghost flights'
Calais crisis: The seven claims made about the migrants - and the reality
- 2 Dutch King Willem-Alexander declares the end of the welfare state
- 4 Giant Minion terrorises drivers in Ireland as 40ft inflatable blocks busy Dublin road
- 5 'Cool kids' can go on to become losers in later life, study finds